Taylan Bozok

Taylan Bozok

Auto-generated profile, based on publicly available information

Taylan Bozok

Department of Medical Microbiology, Faculty of Medicine, Mersin University, 33343 Mersin, Türkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2024 in Infectious Diseases
Verified
Journal Article
Closed access
TBTugce Simsek Bozok
Tugce Simsek Bozok
TBTaylan Bozok
Taylan Bozok
MŞMustafa Serhat Şahinoğlu
Mustafa Serhat Şahinoğlu
HKHamide Kaya
Hamide Kaya
EHElif Şahin Horasan
Elif Şahin Horasan
AKAli Kaya
Ali Kaya
Bloodstream infections (BSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) are a serious threat to public health. In this study, it was aimed to evaluate the risk factors, treatment, length of hospitalisation and mortality of patients with BSI caused by CRKP. Between October 2021 and October 2023, patients aged 18 years and older who were treated for BSI at Mersin University Faculty of Medicine Hospital and had pathogens identified as CRKP or carbapenem-sensitive Klebsiella pneumoniae (CSKP) were retrospectively reviewed and included in the study. Of the 107 patients with BSI included in the study, 66 (61.7%) had CRKP and 41 (38.3%) had CSKP. The risk factors associated with CRKP in BSIs were found to be acute renal failure (p = 0.048), mechanical ventilation (MV) (p = 0.042), post-earthquake period (p = 0.022) and use of carbapenem (p < 0.0005) and other beta-lactam antibiotics (p = 0.039). Mortality was significantly higher in BSIs caused by CRKP (80.3%/29.3%, p < 0.0005). In the CRKP group, intensive care unit follow-up (p = 0.020), intubation (p = 0.039), MV monitoring (p = 0.025) and concomitant pneumonia (p = 0.043) significantly increased mortality. There were no significant differences in treatment outcomes between ceftazidime-avibactam and carbapenem combinations (p > 0.05). In the CRKP group, the duration of treatment and hospital stay were significantly longer in patients who started treatment three days or later (p = 0.036/p = 0.011). This study demonstrates that identifying risk factors for BSIs caused by CRKP and implementing early treatment protocols may lead to a reduction in treatment time and mortality rate.

30 April 2020 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
BSBedia Mutay Suntur
Bedia Mutay Suntur
HKHava Kaya
Hava Kaya
HEHalime Betül Şahin Eker
Halime Betül Şahin Eker
BKBanu Kara
Banu Kara
TBTaylan Bozok
Taylan Bozok
NÜNevzat Ünal
Nevzat Ünal
Introduction: This study investigated demographic characteristics and the prevalence of viremia among anti-HCV-positive patients. Methodology: Hospital records of adult patients with anti-HCV positivity between June 2016 and October 2018 were screened retrospectively. Demographic characteristics, genotype distribution, history of injection drug use (IDU), treatment data of HCV RNA-positive patients were investigated. Results: The rate of anti-HCV seropositivity was 1.7% and 54.5% of these were viremic. 69.5% of the 869 viremic patients were male. The mean age was 62 ± 15 (18–95) years for women and 42 ± 19 (18-90) years for men (p < 0.0001). 42.7% of these patients had IDU history. Regarding age, patients with IDU history accounted for 95% of the 18–29 age group. The most common genotype in patients younger than 40 was genotype 3, and genotype 1b in those older than 40. Only 52% of viremic patients had received DAA therapy. Also, 62.2% of patients aged < 40 and 36% of patients > 40 did not receive treatment (p < 0.0001). The SVR12 rate in patients receiving DAA treatment and follow-up was 100%; SVR24 was 99.5%. Conclusions: A shift in the demographic structure of HCV-infected patients due to the changing trends of the HCV transmission mode was observed in this study. On the other hand, the proportion of patients who received DAA therapy was low. A substantial proportion of untreated patients were young with a history of IDU. This indicates that without strategies targeting the patients, the patient load due to HCV-related cirrhosis and hepatocellular carcinoma may persist in the future.

25 August 2021 in Mersin Üniversitesi Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
TBTaylan Bozok
Taylan Bozok
TBTugce Simsek Bozok
Tugce Simsek Bozok
Amaç: Bu çalışmada ishal ön tanılı hastaların rotavirüs, enterik adenovirüs ve enterik parazit inceleme sonuçlarının demografik verilerle ilişkilerinin analiz edilmesi amaçlandı. Yöntem: Ocak 2014 – Aralık 2019 tarihleri arasında Niğde Eğitim ve Araştırma Hastanesi laboratuvarında taze dışkı örneğinde immünkromatografik yöntemle çalışılmış rotavirüs, adenovirüs antijeni ve ışık mikroskobu altında 40x büyütmede parazit inceleme sonuçları retrospektif olarak değerlendirildi. Test sonuçları yaşa, cinsiyete, uyruğa, mevsimlere, yıllara ve hastaneye başvuru şekline göre ki-kare yöntemi ile analiz edildi. p değeri <0.05 istatistiksel olarak anlamlı kabul edildi. Bulgular: İncelenen altı yıllık rotavirüs, adenovirüs ve dışkıda parazit inceleme testlerinin pozitiflik oranları; rotavirüs için %7.7, adenovirüs için %2.3 ve parazit inceleme için %16.8 olarak bulundu. Rotavirüs ve adenovirüs pozitifliği en yüksek 0-2 yaş grubunda (%11.1), parazit görülme oranları ise en yüksek 6-10 yaş grubunda (%23.9) tespit edildi. Rotavirüs pozitifliği kış aylarında, parazit görülme oranları ise yaz aylarında yüksek bulundu (p<0.001). Adenovirüs pozitifliği ise sonbahar ve kış aylarında yüksek oranda tespit edildi (p=0.009). Rotavirüs pozitifliği göçmenlerde daha yüksek oranda tespit edildi (p=0.021). Rotavirüs ve adenovirüs pozitifliği yatan hastalarda, gaitada parazit görülme oranları ayaktan başvuran hastalarda yüksek bulundu (p<0.001). Sonuç: Bölgemizde klinik tanı açısından rotavirüs ve adenovirüse bağlı gastroenteritlerin özellikle kış aylarında ve beş yaş ve altı çocuklarda daha fazla görüldüğü, bunun yanında parazitlere bağlı gastroenteritlerin de yaz aylarında ve 6-10 yaş arası çocuklarda daha sık rastlandığı göz önünde bulundurulmalıdır.

6 August 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
AOAli Ozturk
Ali Ozturk
TBTaylan Bozok
Taylan Bozok
TBTugce Simsek Bozok
Tugce Simsek Bozok
The purpose of this study was to evaluate the SARS‐CoV‐2 immunoglobulin M/immunoglobulin G (IgM/IgG) rapid antibody test results in symptomatic patients with COVID‐19 and their chest computed tomography (CT) data. A total of 320 patients admitted to our hospital for different durations due to COVID‐19 were included in the study. Serum samples were obtained within 0–7 days from COVID‐19 patients confirmed by reverse‐transcription polymerase chain reaction (RT‐PCR) and chest CT scan. According to the SARS‐CoV‐2 RT‐PCR results, the patients included in the study were divided into two groups: PCR positive group (n = 46) and PCR negative group (n = 274). The relationship between chest CT and rapid antibody test results were compared statistically. Of the 320 COVID‐19 serum samples, IgM, IgG, and IgM/IgG were detected in 8.4%, 0.3%, and 11.6% within 1 week, respectively. IgG/IgM antibodies were not detected in 79.7% of the patients. In the study, 249 (77.8%) of 320 patients had positive chest CT scans. Four (5.6%) of 71 patients with negative chest CT scans had IgM and two (2.8%) were both IgM/IgG positive. IgM was detected in 23 (9.2%), IgG in one (0.4%), and IgM/IgG in 35 (14%) of chest CT scan positive patients. The rate of CT findings in patients with antibody positivity was found to be significantly higher than those with antibody negativity. The results of the present study show the accurate and equivalent performance of serological antibody assays and chest CT in detecting SARS‐CoV‐2 within 0–7 days from the onset of COVID19 symptoms. When RT‐PCR is not available, we believe that the combination of immunochromatographic test and chest CT scan can increase diagnostic sensitivity for COVID‐19.

19 July 2023 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
HKHamide Kaya
Hamide Kaya
LELeyla Ersoy
Leyla Ersoy
MÜMahmut Ülger
Mahmut Ülger
TBTaylan Bozok
Taylan Bozok
GAGonul Aslan
Gonul Aslan

15 July 2019 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
TBTaylan Bozok
Taylan Bozok
BKBegüm Kayar
Begüm Kayar
GYGulfer YAKICI
Gulfer YAKICI
EEEmel Eker
Emel Eker
MMMahdi Marzi̇
Mahdi Marzi̇
FKFatih Köksal
Fatih Köksal
Tuberculosis (TB) is a chronic, granulomatous and necrotizing disease caused by microorganisms belonging to the Mycobacterium tuberculosis complex group. In 2017, 6.4 million new TB cases have been reported according to the World Health Organization 2018 Global Tuberculosis Report. TB remains among the major health problems of our time due to the increasing drug resistance problem and the difficulties in definitive diagnosis in recent years. It is stated by clinicians that intensive use of quinolone group drugs with oral form in simple indications such as respiratory or urinary tract infections may lead to resistance and this may result in treatment failures. The aim of this study was to determine the moxifloxacin susceptibility of M.tuberculosis isolates obtained from clinical specimens by phenotypical methods, to determine the resistance rates of moxifloxacin and to investigate the relationship between phenotypical resistance and mutations in the gyrA gene. A hundred (n= 100) consecutive non-multidrug resistant and 37 non-consecutive multidrug resistant M.tuberculosis strains isolated from the clinical specimens of patients with pulmonary tuberculosis were included in the study. The moxifloxacin susceptibility of the isolates was determined by using Löwenstein-Jensen medium and their epidemiological properties were investigated and also mutations detected by gyrA region were compared with drug susceptibility rates. Of the 137 isolates tested for phenotypical susceptibility, 25 (18.2%) were found to be resistant to moxifloxacin. Resistance rate among non-multidrug resistant and multidrug resistant isolates were determined as 17% and 21.6%, respectively. According to the results of the sequencing analysis, of the gyrA regions of all the isolates included in the study, a single base mutation was found in a total of six samples. The location positions of the mutations were determined as D94Y, D94G, A90V, G88A and among two strains as D89N. Two of the isolates with mutations were found to be phenotypically susceptible to moxifloxacin. In our study, it was found that moxifloxacin resistance in M.tuberculosis isolates was higher than similar studies and it was found that different mechanisms may be responsible for the existing resistance other than the mutations in the gyrA gene. It was concluded that the data obtained from the study should be shared with all clinicians in the country due to the possibility of resistance development to this group of drugs in a short time and considering this drug will have an important role in the treatment of TB, it should be used more limited in non-specific indications. Further studies using larger case groups and isolates are needed for the continuation of the research.